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Abstract 
 Unlike most other organisms, the essential five-step Coenzyme A biosynthetic 
pathway has not been fully resolved in yeast. Specifically, the gene(s) encoding the 
phosphopantothenoylcysteine decarboxylase (PPCDC) activity still remains unidentified. 
Sequence homology analyses suggest three candidates, namely Ykl088w, Hal3 and Vhs3, as 
putative PPCDC enzymes in Saccharomyces cerevisiae. Interestingly, Hal3 and Vhs3 have 
been characterized as negative regulatory subunits of the Ppz1 protein phosphatase. Here we 
show that YKL088w does not encode a third Ppz1 regulatory subunit, and that the essential 
roles of Ykl088w and the Hal3/Vhs3 pair are complementary, cannot be interchanged and can 
be attributed to PPCDC-related functions. We demonstrate that while known eukaryotic 
PPCDCs are homotrimers, the active yeast enzyme is a heterotrimer which consists of 
Ykl088w and Hal3/Vhs3 monomers that separately provides two essential catalytic residues. 
Our results unveil Hal3/Vhs3 as moonlighting proteins, involved in both CoA biosynthesis 
and protein phosphatase regulation. 
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 Coenzyme A (CoA, 1) is a ubiquitous and essential cofactor that is utilized by a wide 
variety of enzymes in reactions where it mainly acts as a carrier and activator of acyl groups1, 
2. The CoA biosynthetic pathway has been elucidated in various diverse species, including 
eubacteria (Escherichia coli), plants (Arabidopsis thaliana), and mammals (Homo sapiens)1, 3, 
4. These studies have shown that the pathway is universal and consists of the same five 
enzymatic transformations in all cases, although some diversity exist among the specific 
proteins that catalyze certain steps5. Nonetheless, bioinformatic approaches allow identifying 
(with a few exceptions6) candidate genes encoding the CoA biosynthetic proteins in nearly all 
organisms, including Saccharomyces cerevisiae. 
 Interestingly, sequence homology searches suggest three proteins, namely Hal3, Vhs3 
and Ykl088w, as candidates that may exhibit phosphopantothenoylcysteine decarboxylase 
(PPCDC) activity in S. cerevisiae. PPCDC is a flavoprotein that catalyzes the decarboxylation 
of 4'-phosphopantothenoylcysteine (PPC; 2) to yield 4'-phosphopantetheine (PP; 3), the third 
step in CoA biosynthesis. While previous studies on PPCDCs have shown some diversity 
among these enzymes (e.g. the bacterial variants are usually bifunctional proteins that also 
have phosphopantothenoylcysteine synthetase (PPCS) activity), they all share a common 
mechanism and active site architecture7-11. Furthermore, all PPCDCs characterized so far are 
monogenic. While the three PPCDC candidates in S. cerevisiae are indeed very similar (Vhs3 
and Ykl088w have 49% and 28% sequence identity to the Hal3 protein respectively, see 
Figure 1a), the identification of Hal3 and Vhs3 as potential PPCDCs is in fact surprising as 
both proteins have previously been shown to have functions completely unrelated to CoA 
biosynthesis.  
Specifically, Hal3 (also known as Sis2) is a conserved protein originally identified as a 
halotolerance determinant12 and as a high copy-suppressor of the growth defect of cells 
deficient in the Sit4 protein phosphatase13. Both functions have been linked to a Hal3-
mediated downregulation of the Ser/Thr protein phosphatase Ppz114, since Hal3 binds to the 
carboxy-terminal catalytic domain of Ppz1 and strongly inhibits its phosphatase activity15. 
Decreased activity of Ppz1 leads to salt tolerance, compromised cell integrity and accelerated 
G1/S transition16-21. Similarly, VHS3 was identified as a multicopy suppressor of the G1/S cell 
cycle blockade of a conditional sit4 hal3 mutant22. Vhs3 also acts as a negative regulator of 
Ppz1, albeit less potently than Hal323. In contrast, little is known about YKL088w,  which was 
reported to be an essential gene24 that encodes a protein of roughly similar size to Hal3 and 
Vhs3, sharing a carboxy-terminal acidic tail of about 60 residues with its paralogs (Fig. 1a).  
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Previous studies in our laboratory23 established that the individually viable vhs3 and 
hal3 mutations are synthetically lethal, and that this effect cannot be attributed to an excess of 
Ppz phosphatase activity, thus implying an unknown essential function of the Hal3/Vhs3 pair. 
This finding, in combination with the proposed essentiality of YKL088w and the sequence 
similarity of all three proteins with known PPCDC enzymes, prompted us to consider the 
role(s) of these proteins in CoA biosynthesis. Moreover, we found it especially interesting that 
the homologue of HAL3 in A. thaliana (AtHal3a), while now known to be the PPCDC protein 
of this organism, was previously shown to also play a role in halotolerance.  In fact, the 
AtHal3a protein can partially complement the salt-sensitive phenotype of a hal3 yeast 
mutant25 even though it is smaller than Hal3, lacking both its amino-terminal extension and 
acidic tail (Fig. 1a). 
Extensive biochemical and structural studies of AtHal3a showed it to be a homotrimer, 
with the active sites found at the interfaces of the protomers7, 10, 26. Two key and conserved 
residues were also identified to be important for its PPCDC-catalyzed reaction: His90 and 
Cys175 (Fig. 1b)8-10. These two residues play different roles in the elucidated PPCDC 
mechanism7, 11, 27, 28, which takes place in two steps as shown in Figure 1c. The conserved His 
residue is involved in the first step, the FMN (4)-dependent oxidation of PPC’s cysteine 
moiety, which is followed by the spontaneous decarboxylation of the resulting thioaldehyde 5 
to yield an enethiol intermediate (6). The second step entails reduction of this intermediate to 
4'-phosphopantetheine 3 and reoxidation of the FMNH2 cofactor, and involves the conserved 
Cys residue. These residues seem to be a general feature of PPCDC enzymes from nearly all 
organisms, with the exception of the Archaea29. Importantly, although the His residue is 
conserved in all three candidate yeast PPCDCs, the Cys residue is only conserved in Ykl088w 
(see Figure 1b). This has led to the hypothesis that Ykl088w most likely fulfills the role of S. 
cerevisiae’s PPCDC4, although no studies published to date has definitively addressed this 
question, and the nature of the PPCDC activity in yeast therefore remained unresolved. 
 We set out to elucidate of the roles of the three putative PPCDC proteins in yeast by 
experimentally finding answers to the following key questions: 1) Is Ykl088w a third 
regulatory subunit of the Ppz1 protein phosphatase?; 2) Is the essential role of YKL088w due 
to its unique function as a PPCDC-encoding gene?; and 3) Is the hal3 vhs3 synthetically lethal 
phenotype related to CoA biosynthesis in some way? 
Our results indicate that both Hal3 and Vhs3 are able to execute disparate functions in 
yeast cells, acting as regulatory subunits of a specific Ser/Thr protein phosphatase as well as 
participating in the CoA biosynthetic pathway. In contrast, the essential functions of Ykl088w 
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seem to be solely based on its role in CoA biosynthesis. Taken together, our data allow us to 
present a model for the PPCDC activity in S. cerevisiae (which can be extrapolated to other 
fungi) based on the formation of an atypical heterotrimeric protein consisting of at least one 
protomer each of Ykl088w and Hal3/Vhs3. In combination, these results provide a novel and 
interesting example of multifunctional proteins that also offers a fitting explanation to the 
questions raised above. 
 
RESULTS 
Ykl088w is not an inhibitor of protein phosphatase Ppz1 
 Overexpression of Hal3 or Vhs3 results in clear-cut phenotypes that can be attributed 
to downregulation of Ppz1 activity15, 21, 30. To evaluate the ability of YKL088w to mimic HAL3 
behavior, we transformed wild type and hal3 strains with episomal plasmids carrying the 
HAL3 and the YKL088w genes expressed from their own promoters. As shown in Figure 2a, 
high-copy expression of HAL3 increased tolerance to lithium, whereas expression of 
YKL088w had the opposite effect and resulted in cells less tolerant than those carrying an 
empty plasmid. Remarkably, overexpression of YKL088w did not have any effect in a hal3 
strain. High-level expression of HAL3 aggravates the lytic phenotype of a slt2 MAP kinase 
mutant, which manifests even at the permissive growth temperature of 28ºC15. This is caused 
by an inhibition of the Ppz1 activity that promotes increased turgor pressure20 and can be 
prevented by providing osmotic support to the cells. In Figure 2b we show that 
overexpression of YKL088w in a slt2 mutant, instead of inducing cell lysis, supported 
vigorous growth of the strain. This is also observed when slt2 cells are challenged with 
caffeine (7), a compound that enhances the lytic phenotype of this mutant31. Interestingly, the 
effect was lost when the experiment was carried out in a slt2 hal3 strain. Expression of 
YKL088w was also able to rescue growth of a slt2 strain at the non-permissive temperature 
(37ºC). Further experiments demonstrated that, in contrast to what is seen for HAL3, 
overexpression of YKL088w negatively affected growth of a sit4 strain and aggravated the 
characteristic G1 to S phase transition defect observed in these mutants (Supplementary Fig. 
1). In essence, our experiments indicated that overexpression of YKL088w caused effects 
completely opposite to those expected for a gene encoding a Hal3-like protein.  
We subsequently investigated if Ykl088w could bind and inhibit Ppz1, and designed 
both in vitro and in vivo experiments to this end (see Supplementary Methods). Indeed, 
affinity purification of a GST-fusion of the carboxyl-terminal half of Ppz1 expressed in E. 
coli, and of the same GST-fusion and a GST-Ppz1fusion expressed in yeast cells, allows 
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recovery of small amounts of Ykl088w (Supplementary Figs. 2a and 2b), confirming the 
interaction recently described in a large-scale interactomic approach32. However, and in 
contrast with what was found for Hal3 and Vhs315, 23, binding of Ykl088w to the carboxyl-
terminal half of Ppz1 was not more intense than to the entire protein, suggesting a much 
weaker interaction. Furthermore, bacterially expressed Ykl088w was completely unable to 
inhibit Ppz1 activity as measured using p-nitrophenyl phosphate (9) as substrate, even under 
conditions that allowed nearly full inhibition by Hal3 or Vhs3 (Supplementary Fig. 2c). This 
was confirmed by a different assay based on the dephosphorylation of Reg1 that was 
previously used23 to demonstrate Hal3 and Vhs3 Ppz1-inhibitory capacities (Supplementary 
Fig. 2d).  
Taken together, the experiments presented above indicate that Ykl088w does not 
behave as an inhibitor of Ppz1 in the cell and, therefore, does not share this physiological 
function with Hal3 and Vhs3.  
 
YKL088w and Hal3/Vhs3 are not functionally interchangeable 
 A systematic analysis of yeast deletion mutants reported that a YKL088w null strain, in 
which the entire ORF has been deleted, was unviable24. However, the YKL088w ORF lays 
only 269 bp away from the MIF2/YKL089W stop codon, and MIF2 codes for a kinetochore 
protein whose mutation is deleterious to the cell33. We therefore confirmed the essential 
nature of YKL088w by disruption of the gene in a diploid strain and overexpression of wild 
type YKL088w ORF in the heterozygous diploid mutant, followed by sporulation and tetrad 
analysis (Supplementary Fig. 3). 
Given the similarity between Ykl088w and Hal3 or Vhs3 proteins, as well as the lethal 
effect of the ykl088w and hal3 vhs3 mutations, it was reasonable to test whether 
overexpression of any of these proteins could allow survival of the other deletion mutants. To 
this end, diploid strains heterozygous for the diverse mutations and their combinations were 
prepared and transformed with high copy-number plasmids carrying HAL3, VHS3 or 
YKL088w. Diploids were induced to sporulate and the phenotype of the haploids analyzed by 
a combination of random spore and tetrad analysis. The results in Table 1 show that high 
copy-number expression of YKL088w was unable to rescue lethality of the hal3 vhs3 mutant. 
Similarly, overexpression of HAL3 or VHS3 did not allow rescue of haploid cells bearing the 
ykl088w mutation. The same results were obtained when the HAL3 and YKL088w ORFs were 
cloned in the episomal plasmid pWS93, which provides strong and constitutive expression 
from the ADH1 promoter. These results indicate that, in spite of their structural similarity, the 
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essential function of YKL088w cannot be replaced by HAL3 or VHS3 and that the HAL3/VHS3 
pair provides vital functions that cannot be fulfilled by high levels of Ykl088w. Our repeated 
but unsuccessful attempts to isolate high-copy suppressors of both the ykl088w and the hal3 
vhs3 mutations further suggests that the S. cerevisiae genome does not encode any protein 
able to functionally replace Ykl088w or the pair Hal3/Vhs3, even when overexpressed. 
 
Ykl088w and Hal3/Vhs3 functions relate to CoA biosynthesis 
 To address whether or not the essential functions of Ykl088w and Hal3/Vhs3 could be 
related to CoA biosynthesis and more specifically as proteins with PPCDC activity, we 
reasoned that, if so, lethality would be suppressed by bona fide PPCDC enzymes. Therefore, 
we expressed AtHal3a as well as the human and mouse homologs in heterozygous diploid 
ykl088w, hal3 vhs3 and triple mutant strains, and searched for haploid cells carrying the 
indicated mutations (Table 1). In all cases ykl088w, hal3 vhs3, or even triple mutants were 
recovered as long as they were expressing the heterologous protein. The same result was 
obtained by expressing the E. coli dfp gene, which encodes both PPCS and PPCDC activities 
8, 34. These results strongly suggest that the essential Ykl088w and Hal3/Vhs3 functions are 
involved in the PPCDC activity of CoA biosynthesis. 
 
Reconstitution of yeast PPCDC activity in vitro 
To determine whether the yeast proteins had any PPCDC activity in vitro the Hal3, 
Vhs3 and Ykl088w proteins were expressed in E. coli as GST-fusion proteins and purified. 
The GST-tags were subsequently removed before using an established coupled assay (and the 
human PPCDC enzyme as positive control)11 to verify their activity. Each protein was 
assayed individually, as well in all possible combinations to determine potential synergistic 
effects. The results, summarized in Figure 3a, indicate that while none of the individual 
proteins displayed any significant PPCDC activity, combinations of Hal3/Ykl088w and 
Hal3/Vhs3/Ykl088w were active. Moreover, since addition of Vhs3 to Hal3/Ykl088w (to give 
the Vhs3/Hal3/Ykl088w combination) increases the activity by ~20%, Vhs3 must contribute 
to the catalytic process in some manner. Interestingly, the Vhs3/Ykl088w combination 
exhibited only very low levels of activity. 
 Taken together, the in vitro activity assay results support the conclusions derived from 
the genetic complementation studies, and strongly suggest that PPCDC in yeast requires at 
least Hal3 and Ykl088w to be catalytically active. However, since similar results would be 
obtained whether the proteins were directly involved in the enzymatic transformation or 
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merely activated one protein for PPCDC activity, we set out to clarify their exact role(s) 
through mutational analysis of previously identified conserved PPCDC active site residues. 
 
Mutagenesis analysis of conserved residues in yeast PPCDCs 
 To evaluate the functional relevance of the two conserved catalytic residues of PPCDC 
(His90 and Cys175 in AtHal3a) in the yeast proteins, the conserved His residues of Hal3, 
Vhs3 and Ykl088w and the conserved Cys of Ykl088w were mutated to Ala and Ser 
respectively. The mutated versions were tested for their ability to rescue either the hal3 vhs3 
or ykl088w mutation in all cases where the native proteins were shown to rescue lethality. The 
results (Table 1) show that neither Hal3 H378A nor Vhs3 H459A was able to rescue synthetic 
lethality in the hal3 vhs3 strain, highlighting the importance of the conserved His residue in 
these proteins. In contrast, Ykl088w H391A allowed survival of the ykl088w strain, indicating 
that the conserved His is not functionally relevant in this context. On the other hand, the 
results do show that Ykl088w’s Cys478 is essential, since its C478S mutant was not able to 
rescue the ykl088w deletion.  
 Similar experiments were performed using the plant and human PPCDC proteins 
expressed from the constitutive PMA1 promoter. Table 1 shows that the H90N mutation in 
AtHal3a rendered the protein unable to rescue a hal3 vhs3 mutant, while allowing growth in 
the ykl088w background. Conversely, the C175S mutation produced a protein able to rescue 
the hal3 vhs3 strain, but not the ykl088w deletion mutant. Testing the equivalent C173S 
mutation in the human PPCDC (HsCoaC) gave similar results. Finally, none of the mutated 
versions was able to rescue a triple ykl088w hal3 vhs3 mutant strain. 
These results allow two relevant conclusions to be drawn: 1) the conserved His 
determines the essential function only of the Hal3/Vhs3 pair, but not of Ykl088w, indicating 
that its His391, while conserved, is not required for activity; 2) the conserved Cys of Ykl088w 
is essential. Considering the putative roles of these residues in the two steps of the PPCDC-
catalyzed reaction (Fig. 1c), these conclusions indicate that in yeast either Hal3 or Vhs3 is 
required to perform the first step, and Ykl088w to complete its second step. An analysis of 
known PPCDC structures suggests that such a requirement could be satisfied in an elegant 
fashion by considering a heteromeric model for the yeast PPCDC enzyme. 
 
Proposing a structural model for yeast PPCDC  
The crystal structure of AtHal3a shows that the active protein consists of a 
homotrimeric assembly where each monomer participates in two separate catalytic sites 
 9 
formed at its opposite interfaces (Fig. 3b). For each active site the essential His residue 
contained in motif II (Fig. 1b) is found on one protomer, while the essential Cys is contained 
in the substrate recognition clamp (motif IV) of the adjacent molecule. Using the 
homotrimeric AtHal3a structure as reference, a model of a heterotrimeric yeast PPCDC 
consisting of one molecule each of Hal3, Vhs3 and Ykl088w can be constructed (Fig. 3c and 
Supplementary Fig. 4). This model shows that instead of three, such a heterotrimeric protein 
will only have one single functional active site that contains both the required His (donated by 
either Hal3 or Vhs3) and Cys (donated by Ykl088w) residues. Such a model accounts for the 
complementation experiments described above, and explains why it has not been possible to 
associate the PPCDC activity in yeast with a single protein. However, we must point out that 
based on this analysis, any heteromer (either dimers or trimers) consisting of at least one 
Ykl088w protomer and either Hal3 or Vhs3 would also be active in the manner described 
above. We therefore set out to determine the oligomeric nature of the native yeast PPCDC 
protein through binding and cross-linking experiments. 
 
Confirming the formation of a heterotrimer in vitro 
Our heteromeric model for the active PPCDC in yeast is supported by previous 
findings of several high-throughput interactomics experiments that showed the interaction of 
bait Ykl088w with both Vhs3 and Hal335-37. As these experiments do not distinguish between 
direct and indirect interactions, we incubated Hal3 and Vhs3 (after removal of their GST-tags) 
with GST-Ykl088w bound to glutathione-agarose beads. The beads were extensively washed, 
followed by treatment with PreScission protease to release Ykl088w and any proteins bound 
to it. As shown in Figure 4a, Vhs3 and Hal3 co-eluted with Ykl088w, indicating that 
Ykl088w directly interacts with both Vhs3 and Hal3.The eluted protein mixture was 
subsequently treated with glutaraldehyde to covalently cross-link interacting proteins. Figure 
4a shows that cross-linking results in the disappearance of the individual proteins and in the 
formation of protein species which migrate to a position corresponding to molecular masses in 
the range of 210-240 kDa. Considering that the calculated combined molecular mass of Hal3, 
Vhs3 and Ykl088w is ~211 kDa, this provides strong evidence that Hal3, Vhs3 and Ykl088w 
combine to form a trimeric structure in vitro.  
 
Stoichiometry of the active yeast PPCDC complex  
 Although the cross-linking experiments strongly suggest the formation of a 
heterotrimer in vitro, the activity analyses showed that combinations of Hal3 and Ykl088w 
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have PPCDC activity. It is therefore conceivable that a minimal active PPCDC protein can be 
constituted by joining these proteins in a dimeric complex. To determine if this is indeed the 
case, or if the formation of a trimer is a requirement for activity, we compared the activity of 
mixtures of varying amounts of Hal3 and Ykl088w with a mixture of Hal3, Vhs3 and 
Ykl088w, using a 1:1 mixture of Hal3 and Ykl088w (0.5 μg each) as reference point. The 
results (Fig. 4b) show that, as expected for trimer formation, addition of Hal3 beyond a 2:1 
complex has no further effect on activity. However, activity of the Hal3/Ykl088w complex 
does seem to increase with each corresponding addition of more Ykl088w. While we 
currently cannot provide a satisfactory explanation for this behavior, it does confirm that 
Ykl088w is the limiting factor for PPCDC activity. Finally, since the Hal3/Vhs3/Ykl088w 
mixture has an activity higher than the 1:1 Hal3/Ykl088w mixture (in fact, comparable to that 
of the 2:1 Hal3/Ykl088w mixture), Vhs3 must also take part in the formation of an active 
heteromeric yeast PPCDC protein, and should be able to do so even in the absence of Hal3. 
Indeed, increasing the ratio of Vhs3 to Ykl088w from 1:1 (data in Fig. 3a) to 2:1 (Fig. 4b) 
significantly increases the activity of this complex. 
 
Activity of yeast PPCDCs with mutated conserved residues  
To demonstrate that all three yeast proteins are directly involved in the PPCDC 
activity we expressed the Hal3 H378A, Vhs3 H459A and Ykl088w C478S mutants as GST-
fusion proteins in E. coli, and purified them as for the native proteins. The activity of the two 
most active combinations of proteins, i.e. Hal3/Ykl088w and Hal3/Vhs3/Ykl088w, was 
subsequently assayed, and compared with the same combinations in which one of its members 
is replaced with its mutant version. The results, summarized in Figure 4c (closed bars), shows 
that – as expected – any combination containing Hal3 without an active His, or Ykl088w 
without an active Cys residue displays no significant activity. Furthermore, replacing either 
Hal3 or Vhs3 with its mutated version in the Hal3/Vhs3/Ykl088w complex also reduces its 
activity, although the effect is more pronounced when Hal3 is substituted.  
Importantly, according to our model, complexes containing the Ykl088w C478S 
mutant should still be able to catalyze at least the first half of the PPCDC reaction during 
which CO2 is evolved (see Fig. 1c). Using a CO2-release assay (Fig. 4c, open bars) we 
demonstrate that the mutant does indeed still catalyze the oxidative decarboxylation of 
PPCDC, whereas the His378A Hal3 mutant does not. Interestingly, using this assay there is 
little difference between the activities of the Hal3/Ykl088w and Vhs3/Ykl088w complexes, 
which may suggest that the reduced activity of the latter complex in the overall reaction is 
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related to the stability of the complex, since premature dissociation of the complex would 
prevent the reduction of the intermediate to complete the reaction. 
Taken together, these results provide further evidence that all three proteins are 
directly involved in the PPCDC-catalyzed reaction, with Hal3/Vhs3 and Ykl088w combining 
in heterotrimeric complex(es) in which they each respectively provides the particular active 
site residue required by each of the two PPCDC half-reactions. 
  
Engineering of a homotrimeric S. cerevisiae PPCDC  
With a view to obtaining a functional homotrimeric yeast PPCDC protein, we set out 
to restore the degenerate catalytic motifs of one of the yeast PPCDC protomers to full 
catalytic functionality. To this end we substituted Asn466 in Hal3 with a Cys, but found that 
the resulting protein was still unable to rescue ykl088w lethality (data not shown). Since 
His391 of Ykl088w is not essential in spite of being conserved, we considered whether the 
nearby sequence insertion (see Fig. 5a) had any effect on the local context of this residue. To 
test this hypothesis, we replaced the original AWVFDAVNKNDTSLSLNLILHHE sequence 
in Ykl088w by the corresponding EWSSWNKIGDPVLHIE sequence from Hal3. The 
resulting chimera, Ykl088wHisRep (for His replacement), was expressed from the YKL088w 
promoter in ykl088w and hal3 vhs3 strains, as well as in the triple mutant. As predicted, this 
hybrid protein was not only able to rescue the lethality of the ykl088w strain, but also that of 
the hal3 vhs3 and hal3 vhs3 ykl088w mutants. Remarkably, rescue was achieved even when 
the construct was expressed from a centromeric plasmid, suggesting that its biological activity 
is similar to that of the native PPCDC. These results indicate that Ykl088wHisRep behaves as a 
homomeric PPCDC. Moreover, expression of Ykl088wHisRep in the temperature sensitive 
dfp-707ts E. coli strain7, 38, 39, in contrast to that of wild-type Ykl088w or Hal3, supported 
growth at the restrictive temperature of 37°C (Fig. 5b).  
We also measured the in vitro activity of Ykl088wHisRep prepared and purified as for 
the other proteins. Gratifyingly, the chimeric protein did indeed show activity, although only 
at high protein concentrations (Fig. 5c). However, addition of either Hal3 or Hal3 and Vhs3 to 
the protein mixtures increased activity markedly, suggesting that the low activity of the 
Ykl088wHisRep protein is probably due to its reduced ability to form homomeric complexes. 
 
Exploring fungal genomes for putative PPCDC enzymes 
The proposed heteromeric PPCDC model with interdependent monomers in S. 
cerevisiae, which is clearly different from the homotrimeric PPCDC found in A. thaliana and 
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most other eukaryotes, raised the question of whether the S. cerevisiae PPCDC is an 
exception among fungal enzymes. A query of various fungal protein sequence sets with 
Ykl088w and Hal3 yielded 43 hits in 27 different yeast species (Fig. 6). Three different 
scenarios could be distinguished: in the first, organisms (such as S. cerevisiae) contain three 
putative PPCDC-encoding genes similar to Hal3, Vhs3 and Ykl088w. In the second scenario, 
represented by eight Hemiascomycetes included in the search, only two such genes can be 
identified. Finally, the Archyascomycete S. pombe and most of the Euascomycetes and 
Basidiomycetes have a single putative PPCDC-encoding gene, with the exception of 
Neurospora crassa and Cryptococcus neoformans, which both have duplicate putative 
PPCDC-encoding genes.  
The Hemiascomycetous sequences can be divided into Ykl088w-like (Group1 in 
Figure 6) and Hal3/Vhs3-like classes (Group 2). All members of Group1 lack the conserved 
His residue of motif II (Fig. 1b) but do have a conserved Cys residue in the substrate 
recognition clamp (motif IV) as well as a canonical PXMNXXMW motif (motif III)  
containing the conserved Asn that participates in decarboxylation9. In contrast, all proteins in 
Group 2 lack these Cys and Asn residues, although they maintain the conserved His 
embedded in a sequence context similar to that of AtHal3a. The non-hemiascomycetous 
fungal sequences (Group 3) share all three these signature elements with AtHal3a and human 
PPCDC. These observations indicate that the phylogenetic spread of distinct, functionally 
interdependent Ykl088w-like and Hal3/Vhs3-like PPCDC lines largely overlaps with the 
phylum Hemiascomycetes. S. cerevisiae, Candida glabrata and Vanderwaltozyma polyspora 
each possess two representatives of the Hal3/Vhs3-like group probably as remnants of the 
same relatively recent genome duplication event40 that occurred shortly before the divergence 
of the Saccharomyces and Vanderwaltozyma line. 
 
DISCUSSION 
Hal3, Vhs3 and Ykl088w are three related proteins encoded by the yeast genome. 
Previous work has demonstrated that Hal3 and Vhs3 act in yeast cells as inhibitory subunits of 
the Ppz1 and Ppz2 protein phosphatases, thus controlling a variety of cell functions such as 
saline tolerance or cell cycle progression15, 18, 21, 23, 41. Here we demonstrate that Ykl088w does 
not play a physiological role as regulatory subunit of Ppz1, as it shows only residual Ppz1 
binding capacity and does not affect the phosphatase activity in vitro. This may be explained 
by the fact that Ykl088w does not conserve several residues found in Hal3 to be important for 
efficient Ppz1 binding41 (see Fig. 1b). In addition, the inability of Ykl088w to inhibit Ppz1 
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can be explained by the observation that a conserved Asn in Hal3 (N466) and Vhs3 (N547), 
which is relevant for Ppz1 inhibition41, is exchanged for the catalytically essential Cys478 in 
Ykl088w. The phenotypes observed from the overexpression of the Ykl088w protein, which 
are opposite to those observed for Hal3 overexpression, can therefore be explained by the fact 
that Ykl088w retains some Ppz1 binding capacity without affecting its phosphatase activity. It 
is conceivable that the excess of Ykl088w produced in the cell by a large increase in the gene 
copy number would displace native Hal3 from Ppz1, thus mimicking a situation of absence of 
Hal3 (i.e. a hal3 mutant). This is supported by the observation that the anti-Hal3 effects 
disappear in hal3 mutants (Fig. 2a,b).  
 By a combination of genetic and biochemical approaches we showed here that the 
essential function of Ykl088w is related to its role in CoA biosynthesis, and specifically to 
PPCDC activity. More importantly, we also demonstrate that the synthetic lethality of the 
hal3 vhs3 mutation23 is also a result of disruption of CoA biosynthesis at the PPCDC level. 
Our data indicates that, in contrast with the homotrimeric structure defined for PPCDC in 
plants and mammals, in the yeast S. cerevisiae PPCDC is most probably a heterotrimer 
composed of at least one subunit of Ykl088w and Hal3/Vhs3. Furthermore, in vitro activity 
analysis suggests that the most active combinations consist of Ykl088w and Hal3 on their 
own, or together with Vhs3.  In the latter case two potential heteromeric complexes could be 
formed: one as depicted in Figure 3c, and the other with Vhs3 and Hal3 transposed with Vhs3 
providing the catalytic His residue. Our data suggest that the latter complex has a much lower 
activity. Therefore, S. cerevisiae’s PPCDC is not a monogenic enzyme, but instead consist of 
at least two different gene products that are not functionally exchangeable. Previous work has 
suggested the existence of a 375-400 kDa CoA biosynthesizing complex in S. cerevisiae that 
would involve an alternative pathway for the biosynthesis of CoA (with a decarboxylase 
enzyme acting on 5′-ADP-4′-pantothenoylcysteine (10) to form dephospho-CoA (11))42, 43. In 
this regard, we wish to stress that: 1) In spite of the many reported genome-wide experiments 
to identify protein-protein interactions in S. cerevisiae, no interaction has been described 
between any of the putative CoA biosynthetic proteins (except for interactions of Ykl088w 
with Hal3 and Vhs3), suggesting that the heteromeric PPCDC described here is not related to 
the complex mentioned above. 2) The essential nature of the three proposed components of 
the PPCDC protein in S. cerevisiae indicates that its requirement for PPCDC activity is 
absolute and implies that, if it exists, the alternative pathway would not be physiologically 
relevant. This notion is further supported by our repeated failure to isolate high-copy 
suppressors of both the ykl088w and the hal3 vhs3 mutations, as well as by the observation 
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that all genes encoding the additional enzymes composing the classical pathway from 
pantothenate to CoA are also essential44.  
From the comparative sequence analysis presented above (Fig. 6), it is clear that 
duplications of the classical eukaryotic PPCDC-encoding gene are not infrequent, although 
most of the resulting gene products retain the complete functionality of the ancestral PPCDC 
as judged from signature sequence elements. In Hemicascomycetes, however, this duplication 
was followed by the specialization and consequently the interdependence of the descendent 
lines. It is fair to assume that this cost must have been compensated for by some benefit. It is 
tempting to speculate that a functional connection exists between the Ppz1 phosphatase-
mediated role of Hal3 on the energy-requiring processes of potassium uptake and sodium 
efflux12, 15, 17, 18 and a PPCDC-dependent stimulation of CoA biosynthesis and, indirectly, 
oxidative ATP production. Such an advantage would promote the strengthening of a 
serendipitously acquired affinity of ancestral Hal3/Vhs3 for Ppz1, even at the cost of an 
incremental degeneration of its Cys-centered subsite (which overlaps with the Hal3 region 
implicated in the binding and inhibition of Ppz141).  
Taken together, our results unambiguously map the essential role of Ykl088w in yeast 
to the PPCDC activity of CoA biosynthesis, and in agreement with a very recent report44, we 
suggest that the corresponding gene’s name be changed to CAB3 (for Coenzyme A 
Biosynthesis) to indicate this fact. Furthermore, the case presented here may also illustrate a 
crosstalk between regulatory (Ppz1 inhibition) and metabolic pathways (CoA biosynthesis) 
mediated by the Hal3 and Vhs3 proteins, which would constitute another remarkable example 
of  moonlighting proteins in yeast45. 
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METHODS 
General 
All chemicals were purchased from Aldrich or Sigma Chemical Co. (unless otherwise 
indicated) and were used without further purification. Microplate-based enzyme activity 
measurements were done in either a Multiskan Ascent or Varioskan microplate-based UV 
spectrophotometer (both from ThermoLabsystems).  
 
Yeast Strains and Growth Conditions 
Yeast cells were grown at 28°C in YPD medium (10 g/liter yeast extract, 20 g/liter 
peptone, and 20 g/liter dextrose) or, when indicated, in synthetic minimal (SD) medium46. 
Sporulation , tetrad dissection and random spore analysis were done as previously described 
46, 47. Yeast strains used in this study are described in Supplementary Table 1. 
 
Gene Disruption and Plasmid Construction 
Disruption of YKL088w with the kanMX marker was accomplished by the short 
flanking gene replacement technique using 5’- and 3’-YKL088w_kanMX primers 
(Supplementary Table 2). The VHS3 gene was disrupted with the kanMX or the nat1 marker 
as previously described23. 
Plasmids YEp195-HAL3, YEp195-VHS3, YEp195-HAL3_H378A, YEp195-
VHS3_H459A, pGEX-HAL3, pGEX-VHS3 and pGEX-PPZ1 were previously described23. 
High-copy expression of YKL088w was achieved by inserting a 3139-bp sequence (starting 
from an artificial EcoRI site included at position –773 from the ATG codon of YKL088w and 
ending at the EcoRI site located 647-bp after the stop codon) at the EcoRI site of plasmids 
YEplac195 (URA3 marker), YEplac181 (LEU2 marker), or YEplac112 (TRP1 marker). An 
identical cloning strategy using plasmid YCplac111 (LEU2 marker) allowed low copy 
expression of this gene. Construction of other relevant plasmids is described in 
Supplementary Methods. All plasmids used in this work are listed in Supplementary Table 3. 
  
Cross-linking experiments 
The interaction of Hal3 and Vhs3 with Ykl088w was assessed in vitro as follows. 
GST-Ykl088w, GST-Hal3 and GST-Vhs3 constructs (see above) were introduced into E. coli 
strain BL21(DE3) RIL (Stratagene). GST-Hal3 and GST-Vhs3 were expressed as described23. 
For GST-Ykl088w expression E. coli cultures were grown at 28ºC and IPTG concentration 
reduced to 0.1 mM. Purification using glutathione-agarose beads (GE Healthcare) was 
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performed as described48, except that 50 mM NaH2PO4 (pH 7.0) was used instead of Tris-HCl 
buffer. GST-Hal3 and GST-Vhs3 containing beads were treated with PreScission protease 
(GE Healthcare) to remove the GST moiety as recommended by the manufacturers, except 
that 50 mM NaH2PO4 (pH 7.0) was used as buffer and 10% glycerol was added to the eluted 
samples. Fifty µl of beads containing approximately 10 µg of GST-Ykl088w were mixed with 
45 µl of Hal3 (15 µg) and 60 µl of Vhs3 (15 µg) and incubated at 24 ºC for 40 min. Samples 
were centrifuged and the supernatant removed. Beads resuspended in 200 µl of buffer (50 
mM NaH2PO4 pH 7.0, 150 mM NaCl, 10% glycerol and 0.1% Triton X-100), transferred to 
MultiScreen filter plates (Millipore) and extensively washed with the resuspension buffer. 
Beads were then resuspended in 200 µl of washing buffer and one fifth of the volume was set 
aside to monitor binding of Hal3 and Vhs3 to GST-Ykl088w. The rest was centrifuged and 
the beads (about 40 µl) were resuspended in 50 µl of PreScission buffer and incubated for 7 h 
at 4 ºC with 4 units of the protease. The mixture was transferred again to MultiScreen filter 
plates and the eluate recovered by centrifugation. Thirty µl of the eluate was made 0.005% 
glutaraldehyde by adding 3.3 µl of a 0.05% stock solution and incubated for 20 min at 24 ºC. 
The cross-linking reaction was stopped by incubation with 2 µl of  1 M Tris-HCl pH 7.5 for 5 
min. An equivalent cross-link reaction was carried out with 20 µl of a 0.1 µg/µl solution of 
bovine serum albumin (BSA) as negative control. Samples received the appropriate volume of 
4× sample buffer and were subjected to SDS-PAGE in 6% polyacrylamide gels. 
 
Complementation test with a dfp mutant strain of E. coli 
The constructs expressing the human PPCDC or the yeast genes HAL3, VHS3, YKL088w and 
a version of the latter with the PPC binding motif of HAL3 (YKL088w_HisRep) were 
introduced into the E. coli temperature-sensitive mutant strain BW36938. Transformants were 
cultured on LB plates supplemented with ampicillin at 30°C or 37ºC for 24 h and examined 
for complementation of the dfp mutation. 
 
PPCDC activity assays 
PPCDC activity based on the formation of PP (3) was assayed as described 
previously11 with minor modifications. Assay mixtures (150 µl) contained 60 µl 
pyrophosphate reagent, 0.5 mM PPC (synthesized as described), 2.0 mM ATP, 1.0 mM DTT, 
10 mM MgCl2, 20 mM KCl, ~1.5 µM 6×His-EcCoaD and the putative PPCDC protein or 
proteins in 50 mM Tris-HCl buffer (pH 7.8).  The PPCDC proteins were loaded into the 
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individual wells of a 96-well microplate, followed by a short incubation period at 37°C. The 
reaction was subsequently initiated by addition of the rest of the assay mixture at 37°C, and 
monitored by following the changes in absorbance at 340 nm.  
PPCDC activity based on CO2-formation (i.e. the first PPCDC half-reaction) was 
determined essentially as described previously49 with minor modifications. Assay mixtures 
(150µl) contained 0.5 mM PPC, 5.0 mM MgSO4, 1.0 mM PEP, 0.16 mM NADH, 1.0 mM 
DTT, 1.8 U malate dehydrogenase, 5.5 U lactate dehydrogenase, 0.375 U PEP carboxylase 
and the putative PPCDCs  in 50 mM Tris-HCl (pH 7.6). The PPCDC proteins were loaded 
into the individual wells of a 96-well microplate, followed by a short incubation period at 
37°C. The reaction was subsequently initiated by addition of the rest of the assay mixture at 
37°C, and monitored by following the changes in absorbance at 340 nm.  
The amount of PPCDC in each assay depended on the experiment; for details see the 
Supplementary Methods. Activities were measured in either duplicate or triplicate as 
indicated in the legends to the figures. In all cases the determined activities were corrected for 
an average measured background rate and were normalized to the activity of the 
Hal3/Vhs3/Ykl088w mixture (set at 100%) to allow comparison between experiments. Details 
of the statistical analysis of the data are provided in the Supplementary Methods. 
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FIGURE LEGENDS 
 
Figure 1. Comparison of known and putative PPCDC proteins, and the reaction they catalyze.  
(a) Cartoon comparing A. thaliana AtHal3a with the S. cerevisiae Hal3, Vhs3 and Ykl088w 
proteins, with the core PPCDC domains shown in gold, the N-terminal extensions in blue, and 
the C-terminal acidic tails in pink (uncolored sections denote sequence insertions specific to 
the protein). Numerical values indicate the % sequence identity with the S. cerevisiae Hal3 
protein. The location of the four consensus PPCDC functional motifs (labeled I to IV 
according to Ref. 7) in each protein is also shown; a light grey label indicates that the motif’s 
sequence deviates from the standard pattern. (b) Alignment of the core PPCDC domain of 
AtHal3a with those of Hal3, Vhs3 and Ykl088w, highlighting the sequences of the consensus 
motifs (green background). Residues relevant for PPCDC activity, i.e. the conserved His of 
motif II (AtHal3a H90), the Asn of motif III (AtHal3a N142) and the Cys of motif IV 
(AtHal3a C175) are in boldface on a yellow background. Asterisks denote residues found to 
be necessary in Hal3 for binding or/and inhibition of Ppz141. (c) The reaction catalyzed by the 
PPCDC enzyme proceeds in two steps: the first step involves the flavin-dependent oxidation 
of PPC (2) to the thioaldehyde intermediate (5) and has been shown to require the conserved 
His residue. After the intermediate spontaneously decarboxylates, the conserved Cys residue 
mediates the second step: the reduction of the enethiolate (6) to give the reaction product 4'-
phosphopantetheine (3), and oxidized flavin. 
 
Figure 2. Functional characterization of YKL088w as a putative regulatory subunit of Ppz1. 
(a) Wild type strain JA100 and its hal3 derivative JA104 were transformed with the high-
copy plasmid YEplac195 (YEp195) or the same plasmid carrying the HAL3 (YEp-HAL3) or 
YKL088w (YEp-YKL088w) genes. Cells were spotted on YPD plates containing the indicated 
concentrations of LiCl and growth monitored after 48 h at 28 ºC. (b) Strains JC10 (slt2) or 
EDN101 (slt2 hal3) were transformed as above and grown for 50 h on YPD plates 
supplemented as indicated at 28 ºC or 37 ºC. Caffeine (7) concentration was 1 mM for slt2 
cells and 7 mM for slt2 hal3 cells. The concentration of sorbitol (8), employed as osmotic 
cushion, was 1 M.   
 
Figure 3. In vitro activity analysis of putative yeast PPCDCs allows the proposal of a model 
for functional S. cerevisiae PPCDC. (a) PPCDC activity (based on product (3) formation) of 
0.5 μg each of Hal3 (H), Vhs3 (V), Ykl088w (Y) individually and in various combinations as 
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indicated. The data shown are the average of three replicates, are corrected for an average 
measured background rate and were normalized to the activity of the Hal3/Vhs3/Ykl088w 
mixture (0.5 μg of each), which is roughly equivalent to the activity of ~0.73 μg (30 pmol) 
HsCoaC used as positive control. Error bars denote s.d.  (b) A cartoon of the homotrimeric A. 
thaliana PPCDC enzyme (AtHal3a), showing the active sites containing the conserved His 
and Cys residues at the interfaces of the protomers. (c) A cartoon of the proposed 
heterotrimeric structure of a potentially active S. cerevisiae PPCDC enzyme consisting of one 
protomer each of Hal3, Vhs3 and Ykl088w, with the predicted single functional active site 
highlighted. A model in which the Hal3 and Vhs3 protomers are interchanged should give a 
similarly active enzyme. 
 
Figure 4. The yeast PPCDC is a trimer consisting of Hal3, Vhs3 and Ykl088w. (a) SDS-
PAGE analysis of Hal3 and Vhs3 pulled-down with immobilized Ykl088w, followed by 
cross-linking: (1) Hal3; (2) Vhs3; (3) GST-Ykl088w-containing beads; (4) sample 3 incubated 
with purified Hal3 and Vhs3; (5) material eluted from sample 4 after cleavage of Ykl088w 
from beads; (6) sample 5 cross-linked with 0.005% glutaraldehyde (~2× the amount loaded); 
(7) 2 µg BSA; (8) 2 µg BSA after cross-linking. The ~70 kDa protein present in all 
recombinant yeast samples is probably of E. coli origin. (b) Stoichiometric activity analysis of 
binary mixtures of Hal3 (H) and Ykl088w (Y) relative to the ternary Hal3/Vhs3/Ykl088w 
combination (values indicate each protein’s quantity in μg). The H:0.5,Y:0.5 sample’s 
activity is significantly different from those of the two samples with increased amounts of 
either H or Y (P<0.05, unpaired t-test assuming equal variance). The data are the average of 
two replicates (corrected and normalized as in Figure 3a), with error bars denoting s.d. (c) 
Activity analysis based on product formation (closed bars) and CO2 release (open bars) of 
Ykl088w-containing native combinations, compared to the same combinations in which 
conserved His or Cys residues have been mutated. H*, Hal3 H378A; V*, Vhs3 H459A; Y*, 
Ykl088w C478S. The data are the average of three replicates (corrected and normalized as in 
Figure 3a), with error bars denoting s.d. Asterisks above the bars indicate the confidence level 
in the values being significantly different from zero (*, P<0.05; **, P<0.01). N.d., not 
determined. 
 
Figure 5. Replacement of the sequence of Ykl088w’s motif II with the sequence of the same 
motif from Hal3 results in a functional PPCDC protein. (a) Alignment of residues 
surrounding AtHal3a’s conserved His90 and the equivalent regions of Hal3, Vhs3 and 
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Ykl088w. Shaded sequences indicate the Hal3 sequence engineered to replace equivalent 
Ykl088w sequence. The conserved His is enlarged and other conserved residues are denoted 
in boldface. (b) E. coli strain BW369 (dfp-707ts), which carries a mutation that abolishes 
PPCDC activity at 37 ºC, was transformed with the indicated plasmids expressing the human 
PPCDC (pPROEX-HsCoaC), all three native yeast proteins and reconstructed 
YKL088w_HisRep. Transformants were grown at 30 and 37 ºC (permissive and non-
permissive temperatures, respectively). (c) PPCDC activity (based on product formation) of 
the engineered homomeric Ykl088wHisRep protein (YHR) present in various amounts (in μg) 
as indicated, and in combination with Hal3 and Vhs3. Hal3 (3.0 μg), Vhs3 (3.0 μg) and 
Ykl088w (1.5 μg) were used as negative controls; only Hal3 is shown. The data are the 
average of three replicates (corrected and normalized as in Figure 3a), with error bars 
denoting s.d. Asterisks above the bars indicate the confidence level in the values being 
significantly different from zero (*, P<0.05; **, P<0.01). 
 
Figure 6. The divergence of PPCDC monomers in yeasts. Forty-three protein sequences of 
putative yeasts PPCDC were aligned using the ClustalW2 algorithm at the EMBL-EBI server 
and a phylogenetic tree was generated (iteration parameter was set to “tree” and clustering 
was performed by the Neighbour-Joining method). The unrooted tree was draw with the 
Phylodraw software50 and labels were added manually. S. cerevisiae proteins are denoted in 
boldface. Shaded groups (1 and 2) correspond to proteins found in Hemiascomycetous yeast. 
See main text for details. 
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Table 1. The diploid strains MAR25 (ykl088w/YKL088w), AGS4 (hal3/HAL3 vhs3/VHS3) 
and AGS31 (ykl088w/YKL088w hal3/HAL3 vhs3/VHS3) were transformed with plasmids 
bearing wild type or mutated versions of S. cerevisiae HAL3, VHS3 and YKL088w, as well as 
plant (AtHal3a), mouse (MmCoaC), human (HsCoaC) and E. coli (dfp) PPCDCs. The ability 
to recover viable cells was monitored by a combination of tetrad analysis and/or random spore 
analysis. The (+) symbol indicates that expression of the gene rescues the lethal phenotype in 
haploid derivatives, whereas (-) denotes the inability to do so. n.d., not determined. 
 
    Heterozygous diploid strain  
 
Gene Version 
 
hal3 vhs3 ykl088w hal3 vhs3 ykl088w 
 
        
 HAL3 WT  + - n.d.  
 VHS3 WT  + - n.d.  
 YKL088w WT  - + n.d.  
        
 AtHal3a WT  + + +  
 MmCoaC WT  + + +  
 HsCoaC WT  + + +  
 E. coli dfp WT  + + +  
        
 HAL3 H378A  - n.d. n.d.  
 VHS3 H459A  - n.d. n.d.  
 YKL088w H391A  n.d. + n.d.  
 YKL088w C478S  n.d. - n.d.  
        
 AtHal3a H90A  - + -  
 AtHal3a C175S  + - -  
 HsCoaC C175S  + - -  
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